188 related articles for article (PubMed ID: 37017557)
41. Long-term efficacy and quality of life associated with laparoscopic bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis.
Liu M; Cheng Z; Dai H; Qu X; Kang L
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():20-4. PubMed ID: 24647206
[TBL] [Abstract][Full Text] [Related]
42. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
43. Alternative treatments of adenomyosis - an update in procedural management and clinical outcomes.
Zeccola AM; Allen SE
Curr Opin Obstet Gynecol; 2024 Aug; 36(4):287-295. PubMed ID: 38837727
[TBL] [Abstract][Full Text] [Related]
44. Preoperative MRI Classification May Not Predict Symptom Relief after Uterine Artery Embolization in Patients with Adenomyosis.
Guo WB; Hu SQ; Wan TT; Wu ZQ; Chen S; Yang JY
Curr Med Sci; 2021 Dec; 41(6):1252-1256. PubMed ID: 34839435
[TBL] [Abstract][Full Text] [Related]
45. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
46. Percutaneous High Frequency Microwave Ablation of Uterine Fibroids: Systematic Review.
Ierardi AM; Savasi V; Angileri SA; Petrillo M; Sbaraini S; Pinto A; Hanozet F; Marconi AM; Carrafiello G
Biomed Res Int; 2018; 2018():2360107. PubMed ID: 29511672
[TBL] [Abstract][Full Text] [Related]
47. Ultrasound-guided percutaneous microwave ablation of adenomyosis: a narrative review.
Zhang S; Wang K; Di A; Yu D; Yao T
Ann Palliat Med; 2021 Nov; 10(11):12003-12011. PubMed ID: 34872323
[TBL] [Abstract][Full Text] [Related]
48. Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.
Chu Z; Jia L; Dai J; Wu Q; Tian F; Bai S
J Ovarian Res; 2024 Jan; 17(1):16. PubMed ID: 38216945
[TBL] [Abstract][Full Text] [Related]
49. Effects of high-intensity focused ultrasound combined with levonorgestrel-releasing intrauterine system on patients with adenomyosis.
Cai Y; Sun Y; Xu F; Wu Y; Ren C; Hao X; Gao B; Cao Q
Sci Rep; 2023 Jun; 13(1):9903. PubMed ID: 37336924
[TBL] [Abstract][Full Text] [Related]
50. Conservative adenomyomectomy with transient occlusion of uterine arteries for diffuse uterine adenomyosis.
Kwon YS; Roh HJ; Ahn JW; Lee SH; Im KS
J Obstet Gynaecol Res; 2015 Jun; 41(6):938-45. PubMed ID: 25510633
[TBL] [Abstract][Full Text] [Related]
51. Hysteroscopic excision of symptomatic myometrial adenomyosis: feasibility and effectiveness.
Xia W; Zhang D; Zhu Q; Zhang H; Yang S; Ma J; Pan H; Tong T; Sun J; Zhang J
BJOG; 2017 Sep; 124(10):1615-1620. PubMed ID: 28544260
[TBL] [Abstract][Full Text] [Related]
52. A clinical audit on the efficacy and safety of uterine artery embolisation for symptomatic adenomyosis: Results in 117 women.
Liang E; Brown B; Rachinsky M
Aust N Z J Obstet Gynaecol; 2018 Aug; 58(4):454-459. PubMed ID: 29344938
[TBL] [Abstract][Full Text] [Related]
53. Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea.
Preutthipan S; Herabutya Y
J Obstet Gynaecol Res; 2010 Oct; 36(5):1031-6. PubMed ID: 20846253
[TBL] [Abstract][Full Text] [Related]
54. Menorrhagia and Uterine Volume Associated with Lower Urinary Tract Symptoms in Patients with Adenomyosis.
Li T; Xu XX; Dai Y; Zhang JJ; Lang JH; Leng JH
Chin Med J (Engl); 2017 Jul; 130(13):1552-1556. PubMed ID: 28639570
[TBL] [Abstract][Full Text] [Related]
55. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high-intensity focused ultrasound treatment of adenomyosis and uterine fibroid.
Lee JS; Hong GY; Lee KH; Kim TE
BJOG; 2017 Aug; 124 Suppl 3():18-22. PubMed ID: 28856867
[TBL] [Abstract][Full Text] [Related]
56. Long-term results of uterine artery embolization for symptomatic adenomyosis.
Kim MD; Kim S; Kim NK; Lee MH; Ahn EH; Kim HJ; Cho JH; Cha SH
AJR Am J Roentgenol; 2007 Jan; 188(1):176-81. PubMed ID: 17179361
[TBL] [Abstract][Full Text] [Related]
57. Laparoscopic Surgery for Focal Adenomyosis.
Kwack JY; Kwon YS
JSLS; 2017; 21(2):. PubMed ID: 28642638
[TBL] [Abstract][Full Text] [Related]
58. Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.
Zheng R; Zeng D; Wan TT; Guo WB; Guo Y; Liu MJ
Diagn Interv Radiol; 2018 Nov; 24(6):364-371. PubMed ID: 30373724
[TBL] [Abstract][Full Text] [Related]
59. Outcome of uterine functional structures protection by fertility preservative PUSH surgery in diffuse adenomyosis.
Wu R; Zeng L; Hu Q; Qu X; He F; Bao J; Wei W; Zhang W; Dai W; Li H; Du H; Li C
Hum Fertil (Camb); 2023 Oct; 26(4):720-732. PubMed ID: 37913797
[TBL] [Abstract][Full Text] [Related]
60. Fifteen cases clinical analysis of wedge-shaped resection of uterus treating adenomyosis-CONSORT.
Shu S; Luo X; Wang Z; Yao Y
Medicine (Baltimore); 2016 Jun; 95(24):e3805. PubMed ID: 27310956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
